Codexis, Inc. (0I0X.L)

USD 5.58

(-2.26%)

Total Liabilities Summary of Codexis, Inc.

  • Codexis, Inc.'s latest annual total liabilities in 2023 was 49.94 Million USD , down -52.7% from previous year.
  • Codexis, Inc.'s latest quarterly total liabilities in 2024 Q2 was 70.55 Million USD , up 0.38% from previous quarter.
  • Codexis, Inc. reported annual total liabilities of 105.59 Million USD in 2022, up 28.79% from previous year.
  • Codexis, Inc. reported annual total liabilities of 81.99 Million USD in 2021, up 59.07% from previous year.
  • Codexis, Inc. reported quarterly total liabilities of 70.29 Million USD for 2024 Q1, up 40.74% from previous quarter.
  • Codexis, Inc. reported quarterly total liabilities of 70.55 Million USD for 2024 Q2, up 0.38% from previous quarter.

Annual Total Liabilities Chart of Codexis, Inc. (2023 - 2006)

Historical Annual Total Liabilities of Codexis, Inc. (2023 - 2006)

Year Total Liabilities Total Liabilities Growth
2023 49.94 Million USD -52.7%
2022 105.59 Million USD 28.79%
2021 81.99 Million USD 59.07%
2020 51.54 Million USD 18.34%
2019 43.55 Million USD 98.19%
2018 21.97 Million USD -24.42%
2017 29.07 Million USD 75.71%
2016 16.54 Million USD -23.98%
2015 21.76 Million USD -0.2%
2014 21.81 Million USD 25.66%
2013 17.35 Million USD -19.36%
2012 21.52 Million USD -35.23%
2011 33.23 Million USD -2.08%
2010 33.93 Million USD -45.44%
2009 62.2 Million USD -68.9%
2008 200 Million USD -0.5%
2007 201 Million USD 102.17%
2006 99.42 Million USD 0.0%

Peer Total Liabilities Comparison of Codexis, Inc.

Name Total Liabilities Total Liabilities Difference
Xeris Biopharma Holdings, Inc. 347.58 Million USD 85.63%
Arrowhead Pharmaceuticals, Inc. 478.39 Million USD 89.56%
Viridian Therapeutics, Inc. 48.4 Million USD -3.19%
Organovo Holdings, Inc. 2.74 Million USD -1717.54%